Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 312524, 10 pages
http://dx.doi.org/10.1155/2011/312524
Research Article

Toxicity and Neuropharmacological Effects of Elenine

1Department of Pharmacology, Faculty of Medicine, University of La Laguna, La Laguna, 38071 Tenerife, Spain
2Department of Medical and Surgical Sciences, University of Las Palmas, Gran Canaria, 35001 Canary Islands, Spain

Received 16 December 2010; Revised 22 February 2011; Accepted 15 March 2011

Copyright © 2011 Eduardo Navarro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Pérez de Paz and C. E. Hernández Padrón, “Plantas Medicinales o útiles en la Flora Canaria,” S. C. Lemus , Ed., pp. 68–69, Tenerife, Spain, 1999. View at Google Scholar
  2. V. Darias, L. Bravo, R. Ravanal, C. S. Mateo, R. González Luis, and A. M. H. Pérez, “New contribution to the ethnopharmacological study of the canary islands,” Journal of Ethnopharmacology, vol. 25, no. 1, pp. 88–89, 1989. View at Google Scholar · View at Scopus
  3. A. Kato, Y. Hashimoto, and M. Kidohoro, “A new pharmacologically active lignan from Wistroemia Indica,” Journal of Natural Products, vol. 42, pp. 159–162, 1979. View at Google Scholar
  4. S. Ghosal, S. Banerjee, and A. W. Frahm, “Prostalidins A, B, C and retrochinensin: a new antidepressant: 4-aryl-2,3-naphthalide lignans from Justicia prostata,” Chemistry and Industry, vol. 23, pp. 854–855, 1979. View at Google Scholar · View at Scopus
  5. S. Ghosal, S. Banerjee, and D. K. Jaiswal, “New furofurano lignan from Justicia simplex,” Phytochemistry, vol. 19, no. 2, pp. 332–334, 1980. View at Google Scholar · View at Scopus
  6. G. J. Dobb and R. H. Edis, “Coma and neuropathy after ingestion of herbal laxative containing podophyllin,” Medical Journal of Australia, vol. 140, no. 8, pp. 495–496, 1984. View at Google Scholar
  7. D. P. Ascher and R. A. Delaney, “Acute dystonia from etoposide,” Drug Intelligence and Clinical Pharmacology, vol. 22, no. 1, pp. 41–42, 1988. View at Google Scholar · View at Scopus
  8. J. Harris and L. J. Dodds, “Handling waste from patients receiving cytotoxic drugs,” Pharmaceutical Journal, vol. 235, pp. 289–291, 1985. View at Google Scholar
  9. J. Trujillo, E. Jorge, E. Navarro, and J. Boada, “Lignans from Justicia hyssopifolia,” Phytochemistry, vol. 29, no. 9, pp. 2991–2993, 1990. View at Google Scholar · View at Scopus
  10. E. Navarro, S. J. Alonso, P. J. Alonso, J. Trujillo, E. Jorge, and C. Perez, “Pharmacological effects of elenoside, an arylnaphthalene lignan,” Biological and Pharmaceutical Bulletin, vol. 24, no. 3, pp. 254–258, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Navarro, S. J. Alonso, R. Navarro, J. Trujillo, and E. Jorge, “Elenoside increases instestinal motility,” World Journal of Gastroenterology, vol. 12, no. 44, pp. 7143–7148, 2006. View at Google Scholar · View at Scopus
  12. E. Navarro, S. J. Alonso, J. Trujillo, E. Jorge, and C. Pérez, “General behavior, toxicity, and cytotoxic activity of elenoside, a lignan from Justicia hyssopifolia,” Journal of Natural Products, vol. 6, no. 1, pp. 134–135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Alonso, E. Navarro, J. Trujillo, E. Jorge, and C. Pérez, “Profile of activity and cytotoxic screening of elenoside,” Methods Findings in Experimental and Clinical Pharmacology, vol. 19, pp. 186–187, 1997. View at Google Scholar
  14. E. Navarro, S. J. Alonso, J. Trujillo, E. Jorge, and C. Pérez, “Central nervous activity of elenoside,” Phytomedicine, vol. 11, no. 6, pp. 498–503, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Sperman and G. Karber, “Inernational Encyclopedia, of Pharmacology and Therapeutics (Section 7),” in Biostatistics in Pharmacology, Pergamon Press, Oxford, UK, 1973. View at Google Scholar
  16. S. Irwin, “Comprehensive observational assessment: a systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse,” Psychopharmacologia, vol. 13, no. 3, pp. 222–257, 1968. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. S. Lim, Pharmacologic Techniques in Drug Evaluation, Year Book Medical Publishes, Chicago, Ill, USA, 1964.
  18. A. D. Rudzik, J. B. Hester, A. H. Tang, R. N. Stray, and W. Friss, “In the benzodiazepines,” Raven Press, NewYork, NY, USA, 1973. View at Google Scholar
  19. T. H. Tyler, R. Tessel, D. Afonso, and M. Rodríguez, “A new device for simultaneous measurement of locomotor and stereotypic frequency in mice,” Psychopharmacology, vol. 64, no. 3, pp. 285–290, 1979. View at Google Scholar · View at Scopus
  20. S. J. Alonso, M. A. Castellano, D. Afonso, and M. Rodriguez, “Sex differences in behavioral despair: relationships between behavioral despair and open field activity,” Physiology and Behavior, vol. 49, no. 1, pp. 69–72, 1991. View at Publisher · View at Google Scholar
  21. W. D. Macrae and N. G. H. Towers, “Justicia pectoralis: a study of the basis for its use as a hallucinogenic snuff ingredient,” Journal of Ethnopharmacology, vol. 2, no. 1, pp. 93–111, 1984. View at Google Scholar
  22. H. Gerad Vogel, Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, Springer, New York, NY, USA, 2006.
  23. C. Morales, MA. P. Gómez-Serranillos, I. Iglesias, A. M. Villar, and A. Cáceres, “Preliminary screening of five ethnomedicinal plants of Guatemala,” Farmaco, vol. 56, no. 5-7, pp. 523–526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Moscardo, A. Maurin, R. Dorigatti, P. Champeroux, and S. Richard, “An optimised methodology for the neurobehavioural assessment in rodents,” Journal of Pharmacological and Toxicological Methods, vol. 56, no. 2, pp. 239–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. D. Perez-Raya, S. Risco, C. Navarro, J. Jimenez, and J. Cabo, “Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics,” Pharmaceutica Acta Helvetiae, vol. 64, no. 5-6, pp. 146–150, 1989. View at Google Scholar
  26. S. Sakitama, “The effects of centrally acting muscle relaxants on the intrathecal noradrenaline-induced facilitation of the flexor reflex mediated by group II afferent fibers in rats,” Japanese Journal of Pharmacology, vol. 63, no. 3, pp. 369–376, 1993. View at Google Scholar
  27. H. Kuribara, Y. Higuchi, and S. Tadokoro, “Effects of central depressants on rota rod and traction performances in mice,” Japan Journal of Pharmacology, vol. 27, no. 1, pp. 117–126, 1977. View at Google Scholar · View at Scopus
  28. W. D. Macrae and G. H. Towers, “An ethnopharmacological examination of virola elongata bark: a South American arrow poison,” Journal of Ethnopharmacology, vol. 2, no. 1, pp. 93–111, 1984. View at Google Scholar · View at Scopus
  29. J. A. Gray, “Sex differences in the emotional behaviour of laboratory rodents,” The British Journal of Psychology, vol. 70, no. 1, pp. 35–36, 1979. View at Google Scholar · View at Scopus
  30. J. Archer, “Rodent sex differences in emotional and related behavior,” Behavioral Biology, vol. 14, no. 4, pp. 451–479, 1975. View at Google Scholar · View at Scopus
  31. C. Gentsch, P. Lichtsteiner, P. Driscoll, and H. Feer, “Differential hormonal and physiological responses to stress in Roman high- and low-avoidance rats,” Physiology and Behavior, vol. 28, no. 2, pp. 259–263, 1982. View at Publisher · View at Google Scholar
  32. B. Saillenfait and B. Vannier, “Methodological proposal in behavioural teratogenicity testing: assessment of propoxyphene, chlorpromazine, and vitamin A as positive controls,” Teratology, vol. 37, no. 3, pp. 185–199, 1988. View at Google Scholar · View at Scopus
  33. E. Navarro, J. Boada, R. Rodriguez, P. Martín, J. Bretón, and A. G. González, “Pharmacological study of uzarigenin-glucoside-canaroside,” Planta Medica, vol. 6, pp. 498–500, 1985. View at Google Scholar · View at Scopus
  34. L. Zhang and X. Niu, “Effects of schizandrol a on monoamine neurotransmitters in the central nervous system,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 13, no. 1, pp. 13–16, 1991. View at Google Scholar · View at Scopus
  35. P. J. Houghton, “The scientific basis for the reputed activity of valerian,” Journal of Pharmacy and Pharmacology, vol. 51, no. 5, pp. 505–512, 1999. View at Publisher · View at Google Scholar · View at Scopus